Tiny study probes Glucagon's kidney effects
NCT ID NCT06872060
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will give 10 healthy men glucagon (a blood sugar hormone) and measure kidney blood flow using MRI. Researchers want to see if glucagon changes blood flow in different parts of the kidney and whether blocking certain receptors alters that effect. The goal is to better understand how glucagon affects kidney function, which may be important for people with diabetes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Glucagon
- What this could lead to
- If successful, this study could help explain how glucagon influences kidney blood flow, potentially guiding future treatments for kidney problems in diabetes.
- What could go wrong
- This is a very small, early-phase study in only 10 healthy men, so results may not apply to women or people with kidney disease. It is designed to gather knowledge, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Contrast dye Double-Dose: new study tracks kidney fallout in ICU patients
- Could a simple breath test spot hidden diseases early?
- Steroids for kidney disease: do they prevent failure Long-Term?
- New drug shows promise for kidney disease patients
- New implant aims to simplify dialysis fistula monitoring
- Dialysis patients wear heart monitors for a week to uncover hidden risks